Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Lymphoid neoplasia. Laser-capturing the essence of Hodgkin lymphoma.

Greaves P, Gribben JG.

Blood. 2012 Nov 29;120(23):4451-2. doi: 10.1182/blood-2012-09-455873.

2.

Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.

Van Vlierberghe P, De Weer A, Mestdagh P, Feys T, De Preter K, De Paepe P, Lambein K, Vandesompele J, Van Roy N, Verhasselt B, Poppe B, Speleman F.

Br J Haematol. 2009 Dec;147(5):686-90. doi: 10.1111/j.1365-2141.2009.07909.x. Epub 2009 Sep 22.

PMID:
19775296
3.

Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.

Tiacci E, Döring C, Brune V, van Noesel CJ, Klapper W, Mechtersheimer G, Falini B, Küppers R, Hansmann ML.

Blood. 2012 Nov 29;120(23):4609-20. doi: 10.1182/blood-2012-05-428896. Epub 2012 Sep 5.

4.

Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells.

Janz M, Hummel M, Truss M, Wollert-Wulf B, Mathas S, Jöhrens K, Hagemeier C, Bommert K, Stein H, Dörken B, Bargou RC.

Blood. 2006 Mar 15;107(6):2536-9. Epub 2005 Nov 1.

5.

Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma.

Steidl C, Diepstra A, Lee T, Chan FC, Farinha P, Tan K, Telenius A, Barclay L, Shah SP, Connors JM, van den Berg A, Gascoyne RD.

Blood. 2012 Oct 25;120(17):3530-40. doi: 10.1182/blood-2012-06-439570. Epub 2012 Sep 5.

6.

MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.

Nie K, Gomez M, Landgraf P, Garcia JF, Liu Y, Tan LH, Chadburn A, Tuschl T, Knowles DM, Tam W.

Am J Pathol. 2008 Jul;173(1):242-52. doi: 10.2353/ajpath.2008.080009.

7.

Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells?

Bellan C, Lazzi S, Zazzi M, Lalinga AV, Palummo N, Galieni P, Marafioti T, Tonini T, Cinti C, Leoncini L, Pileri SA, Tosi P.

Diagn Mol Pathol. 2002 Mar;11(1):2-8.

PMID:
11854595
8.

Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

Skinnider BF, Elia AJ, Gascoyne RD, Patterson B, Trumper L, Kapp U, Mak TW.

Blood. 2002 Jan 15;99(2):618-26.

9.

Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

Schwering I, Bräuninger A, Klein U, Jungnickel B, Tinguely M, Diehl V, Hansmann ML, Dalla-Favera R, Rajewsky K, Küppers R.

Blood. 2003 Feb 15;101(4):1505-12. Epub 2002 Sep 26.

10.

Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.

Hartmann S, Martin-Subero JI, Gesk S, Hüsken J, Giefing M, Nagel I, Riemke J, Chott A, Klapper W, Parrens M, Merlio JP, Küppers R, Bräuninger A, Siebert R, Hansmann ML.

Haematologica. 2008 Sep;93(9):1318-26. doi: 10.3324/haematol.12875. Epub 2008 Jul 18.

11.
12.

Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity.

Giefing M, Winoto-Morbach S, Sosna J, Döring C, Klapper W, Küppers R, Böttcher S, Adam D, Siebert R, Schütze S.

PLoS One. 2013 Dec 23;8(12):e84928. doi: 10.1371/journal.pone.0084928. eCollection 2013.

13.

Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling.

Küppers R, Klein U, Schwering I, Distler V, Bräuninger A, Cattoretti G, Tu Y, Stolovitzky GA, Califano A, Hansmann ML, Dalla-Favera R.

J Clin Invest. 2003 Feb;111(4):529-37.

14.

Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma.

Slovak ML, Bedell V, Hsu YH, Estrine DB, Nowak NJ, Delioukina ML, Weiss LM, Smith DD, Forman SJ.

Clin Cancer Res. 2011 May 15;17(10):3443-54. doi: 10.1158/1078-0432.CCR-10-1071. Epub 2011 Mar 8.

15.

Gene expression profile of cytokines and chemokines in microdissected primary Hodgkin and Reed-Sternberg (HRS) cells: high expression of interleukin-11 receptor alpha.

Karube K, Ohshima K, Suzumiya J, Kawano R, Kikuchi M, Harada M.

Ann Oncol. 2006 Jan;17(1):110-6. Epub 2005 Nov 15.

PMID:
16291580
16.

Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.

Schwering I, Bräuninger A, Distler V, Jesdinsky J, Diehl V, Hansmann ML, Rajewsky K, Küppers R.

Mol Med. 2003 Mar-Apr;9(3-4):85-95. Erratum in: Mol Med. 2003 Sep-Dec;9(9-12):235.

17.

Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.

Vockerodt M, Wei W, Nagy E, Prouzova Z, Schrader A, Kube D, Rowe M, Woodman CB, Murray PG.

J Pathol. 2013 Aug;230(4):399-409. doi: 10.1002/path.4198.

PMID:
23592216
18.
19.

The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells?

Janz M, Mathas S.

Haematologica. 2008 Sep;93(9):1292-5. doi: 10.3324/haematol.13614. No abstract available.

20.

Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

Skinnider BF, Elia AJ, Gascoyne RD, Trümper LH, von Bonin F, Kapp U, Patterson B, Snow BE, Mak TW.

Blood. 2001 Jan 1;97(1):250-5.

Supplemental Content

Support Center